Learn – Engage – Apply – Perform! GPI has launched LEAP; our new career development & training programme

GPI LEAP creates a clear vision for the most ambitious talent by inspiring individuals from diverse backgrounds to come together, grow and succeed in an innovative and dynamic team. We are passionate about growing and developing a world-class, high-performing team of experts through our challenging programme. In an ever-changing global landscape, GPI LEAP shapes careers … More Learn – Engage – Apply – Perform! GPI has launched LEAP; our new career development & training programme

Pricing policy: Germany – a court ruling as soon as June could set a new tone for AMNOG pricing… but is access becoming a more complex moving target for industry?

Legal questions around the “Mischpreis” pricing approach are still hanging over sickness funds and manufacturers in Germany. The current price setting methodology as part of AMNOG negotiations take average weighted prices and considers the value and price potential across all indications and patient subgroups (‘mixed-price’). This methodology has been noted to be potentially at odds … More Pricing policy: Germany – a court ruling as soon as June could set a new tone for AMNOG pricing… but is access becoming a more complex moving target for industry?

Global Pricing Innovations (GPI) adds experienced, global Pharma Industry executive as Chief Operating Officer (COO) and senior pricing expert to lead pricing and consultancy.

Mark Morrison, who joins as COO, was previously with Novartis and had global and regional leadership roles based in Switzerland (Basel) and Indonesia (Jakarta). As a Global Brand Director Mark led global launches for Cardiovascular and Respiratory innovative pharmaceuticals. Within the Asia – Middle East – Africa region Mark was Franchise Head for the Primary … More Global Pricing Innovations (GPI) adds experienced, global Pharma Industry executive as Chief Operating Officer (COO) and senior pricing expert to lead pricing and consultancy.

What will shape the global pharmaceutical pricing environment in 2018?

One of the advantages of working in a global consultancy and technology solutions firm such as Global Pricing Innovations (GPI), which specializes in pharmaceutical pricing, is the wide exposure one receives to the many different challenges across disease areas, companies, and geographies. This forces us all at GPI to keep on our toes and gives … More What will shape the global pharmaceutical pricing environment in 2018?